It was either serendipity or the anxiety of an entire generation of graduate students coming to a boil, but last fall something triggered an explosion of science advocacy on the Emory University campus in Atlanta. A grad student "advocacy journal club" has sprung to life with 50 members, ambitious plans for organizing more, and a working alliance with the dean and with Emory's Office of Governmental Affairs.

NIH Director Francis Collins yesterday unveiled an unusual open access alliance of 10 "biopharmaceutical" companies and eight nonprofits to wade through the growing flood of bio data on four diseases—Alzheimer's, Type 2 diabetes, and the autoimmune disorders, rheumatoid arthritis and lupus—to identify therapeutic targets and characterize biomarkers. All data and analyses will be publicly shared. The pharma and nonprofit allies will put up $230 million over five years in hopes of making translational sense of the mass of new imaging, "omic" sequencing, and other data on these four diseases with massive impacts on public health. The new alliance is called the Accelerating Medicines Partnership (AMP).

"Why is my bench sticky?" one card asks. If the answers, "Rotation students" or "Because the Bible says so," strike you as particularly funny, then you need to download and print out a new open-source card game called Cards Against Science. It was created by a physicist for scientists including non-physicists (like cell biologists), although with its references to spermatozoa and Drosophila, it wouldn't hurt to know your pipette from your elbow.

It may sound like a spam subject line but you can change the trajectory of your career in a few short weeks. If it sounds too good to be true, consider one of the numerous short-term courses, internships, and fellowships in outside-the-lab science careers that can give you a look at a whole new career track.

Activation Energy Blog